M. D. Rodríguez-Arnao

Dopaminergic Control of Thyrotropin, a-Subunit, Thyrotropin β-subunit, and Prolactin in Euthyroidism and Hypothyroidism: Dissociated Responses to Dopamine Receptor Blockade with Metoclopramide in Hypothyroid subjects*

MF Scanlon, Vivian Chan, M Heath et al. · The Journal of Clinical Endocrinology & Metabolism · 1981 · 46 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Influence of Somatostatin and Growth Hormone-Releasing Factor on Behavior

Ramón Cacabelos, Hisayoshi Niigawa, M. D. Rodríguez-Arnao et al. · Hormone Research · 1988 · 37 citations

Medicine, Endocrinology, Neuroscience +17

Pharmacogenomics of insulin-like growth factor-I generation during GH treatment in children with GH deficiency or Turner syndrome

Adam Stevens, Peter Clayton, Luciano Tatò et al. · The Pharmacogenomics Journal · 2013 · 36 citations · Full text

Medicine, Endocrinology, Genetics +17

GHRH-induced GH response in patients with senile dementia of the Alzheimer type

Ramón Cacabelos, Hisayoshi Niigawa, Yoshiaki Ikemura et al. · European Journal of Endocrinology · 1988 · 28 citations

Medicine, Neurology, Pharmacology +12

Exaggerated Circadian Variation in Basal Thyrotropin (TSH) and in the Dopaminergic Inhibition of TSH Release in Pathological Hyperprolactinemia: Evidence Against a Hypothalamic Dopaminergic Defect

M. D. Rodríguez-Arnao, John R. Peters, S.M. Foord et al. · The Journal of Clinical Endocrinology & Metabolism · 1983 · 25 citations

Medicine, Endocrinology, Pharmacology +15